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Abstract
Hepatitis B virus X protein (HBx) plays an important role in the development of hepatocellular carcinoma (HCC). However,
the mechanism remains unclear. Recently, we have reported that HBx promotes hepatoma cell migration through the
upregulation of calpain small subunit 1 (Capn4). In addition, several reports have revealed that osteopontin (OPN) plays
important roles in tumor cell migration. In this study, we investigated the signaling pathways involving the promotion of
cell migration mediated by HBx. We report that HBx stimulates several factors in a network manner to promote hepatoma
cell migration. We showed that HBx was able to upregulate the expression of osteopontin (OPN) through 5-lipoxygenase (5-
LOX) in HepG2-X/H7402-X (stable HBx-transfected cells) cells. Furthermore, we identified that HBx could increase the
expression of 5-LOX through nuclear factor-kB (NF-kB). We also found that OPN could upregulate Capn4 through NF-kB.
Interestingly, we showed that Capn4 was able to upregulate OPN through NF-kB in a positive feedback manner, suggesting
that the OPN and Capn4 proteins involving cell migration affect each other in a network through NF-kB. Importantly, NF-kB
plays a crucial role in the regulation of 5-LOX, OPN and Capn4. Thus, we conclude that HBx drives multiple cross-talk
cascade loops involving NF-kB, 5-LOX, OPN and Capn4 to promote cell migration. This finding provides new insight into the
mechanism involving the promotion of cell migration by HBx.
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Introduction
Hepatitis B virus (HBV) has oncogenic potential in the
development of hepatocellular carcinoma (HCC). The HBV
genome is a partially double-stranded DNA molecule with four
open reading frames (ORFs), in which S ORF encodes hepatitis
surface antigen (HBs) and C ORF encodes hepatitis core antigen
(HBc). Hepatitis B virus X protein (HBx) is a 17 kDa protein
encoded by the X ORF, which plays a crucial role in
hepatocarcinogenesis [1]. HBx has multiple biological functions,
including interaction with other proteins, mediation of cell
proliferation and apoptosis [2,3]. Recent studies have shown that
HBx is associated with cell migration, implicating HBx in HCC
metastasis. For example, HBx may promote tumor spreading by
facilitating integrin-mediated cell migration and regulating the
adhesion-deadhesion balance of the cells in the primary tumor site
[4], enhancing CD44-mediated HA-interaction efficiency and
modifying the migratory properties of transformed hepatocytes [5]
and inducing matrix metalloproteinase (MMP) activation [6,7,8]. It
has been reported that 5-lipoxygenase (5-LOX) is a key regulator of
malignant mesothelial cell proliferation and survival via a VEGF-
related circuit [9]. Our laboratory previously found that cycloox-
ygenase-2 (COX-2) and 5-LOX were highly expressed in breast
cancer LM-MCF-7 cells and MDA-MB-231 cells, which were
related to breast cancer metastasis [10]. Moreover, our have found
that HBx could upregulate the levels of cyclooxygenase-2 (COX-2)
and 5-lipoxygenase in liver cells [11]. Accordingly, nuclear factor-
kB (NF-kB) plays an instrumental role in carcinogenesis and in the
regulation of immune and inflammatory responses [12]. NF-kB
induces the expression of various target genes related to
proliferation, apoptosis, angiogenesis and metastasis. HBx protein
activates the transcription factor NF-kB by acting on two distinct
cytoplasmic NF-kB inhibitor pathways [13]. Furthermore, HBx can
induce the expression of various target genes through activation of
NF-kB, such as cyclin D1 through the NF-kB2(p52)/BCL-3
complex in the nucleus [14]. HBx induces expression of the CXC
chemokine IP-10 and MIG and increases migration of leukocytes
through the activation of NF-kB [15,16].
Previous studies demonstrated that tumor cell invasion and
metastasis after liver transplantation for HCC was highly
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[17], which belongs to the calpain system [18]. Recently, we have
reported that HBx could promote hepatoma cell migration
through the upregulation of Capn4 [19]. Several reports have
revealed that osteopontin (OPN) plays important roles in tumor
cell adhesion, migration, invasion and angiogenesis [20,21,22,23].
An elevated level of plasma OPN is significantly related to cancer
invasiveness and has a significant impact on tumor development
and patient survival rate [24]. OPN is overexpressed in multiple
tumor tissues and is associated with invasion, progression or
metastasis in numerous human cancers, such as liver [25], breast
and colon [26] cancer. OPN promotes tumor cell migration via
the regulation of multiple signaling pathways and activation of
metastasis-related gene expression. Some downstream effectors of
OPN, including PI3K/Akt, EGFR, HGFR, MMPs, and NF-kB,
mediate critical metastatic processes [27,28,29,30,31]. Therefore,
we hypothesize that 5-LOX, NF-kB/p65 and OPN may be
involved in cell migration mediated by HBx and Capn4.
In the present study, we investigated the signal pathways
involving hepatoma cell migration promoted by HBx. Our finding
shows that HBx drives multiple cross-talk cascade loops to
promote hepatoma cell migration, providing new insight into the
mechanism of development of HBx-mediated HCC.
Results
HBx upregulates the expression of OPN in hepatoma
cells
To investigate whether HBx upregulates the expression of OPN,
we examined the effect of HBx on the promoter activity of OPN.
Our data showed that HBx could significantly enhance the
promoter activity of OPN by luciferase reporter gene assay in a
dose dependent manner (Figure S1A, see Text S1). Meanwhile,
RNA interference (RNAi) targeting HBx mRNA mediated by
pSilencer3.0-X (pSi-HBx) could abolish the increase of OPN
promoter activity in a dose-dependent manner (Figure S1A, see
Text S1). In addition, western blot analysis showed that HBx
upregulated the expression of OPN in HepG2-X (or H7402-X)
cells, respectively (Figure S1B, see Text S1). The knock down of
HBx could attenuate the upregulation of OPN in the cells by pSi-
HBx in a dose-dependent manner (Figure S1B, see Text S1). Thus,
we conclude that HBx is able to upregulate the expression of
OPN.
5-LOX is responsible for the upregulation of OPN
mediated by HBx
5-LOX, a catalyzing enzyme of arachidonic acid, was
overexpressed during multistage tumor progression in many
neoplastic disorders including lung, breast, pancreatic cancers
and HCC HBx-integrated host hepatocytes [32,33]. Our previous
study found that HBx could upregulate 5-LOX and COX-2,
which were involved in proliferation and migration [10,11].
Therefore, we hypothesize that 5-LOX or COX-2 may be
involved in the HBx-mediated OPN upregulation. To answer this
question, we treated HepG2-X cells with MK886 (an inhibitor of
5-LOX) and Indo (an inhibitor of COX-2) for 6 h. Luciferase
reporter gene assays demonstrated that MK886 could abolish the
enhanced promoter activity of OPN in HepG2-X cells in a dose-
dependent manner (Figure 1A). However, the treatment with Indo
failed to affect the promoter activity of OPN (Figure 1A). In
addition, we found that 5-LOX was also able to upregulate the
promote activity of OPN in HepG2 cells, but the luciferase activity
was lower than that in HepG2-X cells (Figure 1A), suggesting that
HBx upregulates OPN through 5-LOX. Furthermore, we found
that siRNA against 5-LOX (Si-5-LOX) could abolish the
increased promoter activity and upregulated expression of OPN
protein in HepG2-X (or H7402-X) cells in a dose-dependent
manner by luciferase reporter gene assay (Figure 1B) and western
blot analysis (Figure 1C). Thus, we conclude that HBx is able to
upregulate the expression of OPN through 5-LOX.
Next, we examined the effect of HBx on the regulation of 5-
LOX. We confirmed that the 5-LOX expression levels were
markedly upregulated in HepG2-X (H7402-X) cells relative to the
HepG2 (H7402) cells by real-time PCR and western blot (Figure
S2A, S2B, see Text S1), which is consistent with our previous study
[11]. HBx RNAi could abolish the upregulation of 5-LOX (Figure
S2A, S2B, see Text S1). Furthermore, the data showed that the
amount of LTB4, a metabolite of 5-LOX, was higher in the
conditioned media of HepG2-X (or H7402-X) cells than that in
HepG2 (or H7402) cells, which could be abolished by RNAi
targeting HBx mRNA (Figure S2C, D, see Text S1).
NF-kB is responsible for the upregulation of 5-LOX
mediated by HBx
Our previous study reported that HBx activates NF-kB/p65
in HepG2-X and H7402-X cell lines [19]. Moreover, we found
that 60 mM PDTC (an inhibitor of NF-kB) could significantly
downregulate the expression of 5-LOX mRNA and protein in
HepG2-X (or H7402-X) cells (Figure 2A and B). In addition,
60 mM PDTC could decrease the amount of released LTB4 in
the conditioned media of HepG2-X (or H7402-X) cells and cell
lysates (Figure 2C). Meanwhile, 100 nM siRNA against NF-kB
p65 was able to attenuate the levels of mRNA and protein of 5-
LOX in HepG2-X (or H7402-X) cells (Figure 2D and E),
which was consistent with the above data. In the control,
immunoblot analysis showed that 60 mM PDTC (or 100 nM
NF-kB p65 siRNA) could successfully downregulate the
expression of NF-kB/p65 in nuclear extracts from HepG2-X
(or H7402-X) cells (Figure 2B and E). Thus, our data suggest
that NF-kB is responsible for the HBx-mediated upregulation
of 5-LOX.
OPN is responsible for the HBx-mediated upregulation of
Capn4
Recently, we have reported that HBx upregulates the expression
of Capn4 through NF-kB to promote cell migration [19]. Previous
studies demonstrated that OPN was significantly associated with
tumor metastasis by activating other metastasis-related genes.
Therefore, we hypothesize that OPN may be correlated with the
HBx-mediated upregulation of Capn4. To address this question,
we examined the effect of OPN knockdown (Si-OPN) on the
promoter activity of Capn4 in HepG2-X (or H7402-X) cells by
luciferase reporter gene assay. The results showed that Si-OPN
could abolish the enhanced promoter activity of Capn4 in a dose-
dependent manner (Figure 3A). Furthermore, we detected an
effect of Si-OPN on the expression of Capn4 at the mRNA and
protein level in HepG2-X (or H7402-X) cells by RT-PCR and
western blot analysis. The data revealed that Si-OPN could
significantly attenuate the HBx-mediated upregulation of Capn4
at the mRNA and protein levels in a dose-dependent manner
(Figure 3B and C). This suggests that OPN is responsible for the
HBx-mediated upregulation of Capn4. To further confirm the role
of OPN in the upregulation of Capn4, we examined the effect of
OPN on the expression of Capn4 by transient transfection of
pcDNA3.0-OPN in HepG2 (or H7402) cells. Luciferase reporter
gene assays showed that the overexpression of OPN led to a strong
enhancement of promoter activity of Capn4 in a dose-dependent
Signal Pathway of Cell Migration Mediated by HBx
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Capn4 mRNA and protein levels were increased in the cells by the
overexpression of OPN in a dose-dependent manner (Figure 3E
and F). Our data suggest that OPN is able to stimulate the
expression of Capn4.
NF-kB is responsible for the OPN-mediated upregulation
of Capn4
It is known that OPN induces NF-kB activation, resulting in the
upregulation of its downstream effectors via attachment to b-3
integrin receptors and the induction of cell spreading and
Figure 1. 5-LOX is responsible for the upregulation of OPN mediated by HBx. (A) The promoter activities of OPN were detected by
luciferase reporter gene assay in HepG2-X and HepG2 cells treated with MK886 or Indo, respectively (**P,0.01, ns, not significant, Student’s t test). (B)
The promoter activity of OPN was detected by luciferase reporter gene assay in HepG2-X (or H7402-X) cells treated with the indicated doses of siRNA
targeting 5-LOX mRNA (Si-5-LOX) (**P,0.01, Student’s t test). (C) The protein levels of OPN, 5-LOX and HBx were examined in the cells by western
blot analysis.
doi:10.1371/journal.pone.0031458.g001
Signal Pathway of Cell Migration Mediated by HBx
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be responsible for the OPN-induced upregulation of Capn4.
Luciferase reporter gene assays revealed that knockdown of NF-kB
(Si-NF-kB) resulted in the abolishment of enhanced OPN-
mediated promoter activity of Capn4 in a dose-dependent manner
(Figure 4A). Additionally, the upregulation of Capn4 mediated by
the overexpression of OPN could be attenuated by Si-NF-kBa t
the mRNA and protein levels in a dose-dependent manner
(Figure 4B and C). Thus, we conclude that NF-kB is responsible
for the OPN-mediated upregulation of Capn4.
OPN is upregulated by Capn4 in a positive feedback
manner
Previously, we found that the tumor cell maintained
proliferation and migration in a positive feedback manner
[10,11,35]. Therefore, we hypothesize that Capn4 may be
involved in the activation of OPN in a positive feedback manner
as well. To test the hypothesis, we determined the effect of
Capn4 on the regulation of OPN in HepG2-X (or H7402-X)
cells by siRNA targeting Capn4 mRNA (Si-Capn4). Interesting-
ly, we found that the enhanced promoter activity of OPN could
Figure 2. NF-kB is responsible for the upregulation of 5-LOX. (A, B and C) HepG2-X (or H7402-X) cells were treated with PDTC (0, 20, 40 and
60 mM) for 6 h. (A) The mRNA levels of 5-LOX were examined by real-time PCR (*P,0.05, ***P,0.001, Student’s t test). (B) The protein levels of 5-LOX
and NF-kB/p65 were examined by western blotting. (C) The amount of LTB4 was detected by ELISA in conditioned media or in cell lysates (**P,0.01,
Student’s t test). (D and E) HepG2-X (or H7402-X) cells were transfected with siRNA targeting NF-kB/p65 mRNA or control siRNAs for 48 h. (D) The
mRNA levels of 5-LOX were measured by real-time PCR (***P,0.001, Student’s t test). (E) The protein levels of 5-LOX and NF-kB/p65 were examined
by western blot analysis.
doi:10.1371/journal.pone.0031458.g002
Signal Pathway of Cell Migration Mediated by HBx
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(Figure 5A). Additionally, the expression of OPN at the levels
of mRNA and protein could be attenuated by Si-Capn4 in a
dose-dependent manner (Figure 5B and C). The data suggest
that OPN is regulated by Capn4 in a positive feedback manner
in HepG2-X (or H7402-X) cells. To further confirm that Capn4
is able to upregulate OPN, we examined the effect of Capn4 on
the expression of OPN by transient transfection of pcDNA3.0-
Capn4 in HepG2 cells. Luciferase reporter gene assays showed
that overexpression of Capn4 led to a strong enhancement of
promoter activity of OPN in a dose-dependent manner in
HepG2 cells (Figure 5D). Furthermore, RT-PCR and western
blot confirmed that the expression levels of OPN were increased
by the overexpression of Capn4 in a dose-dependent manner
(Figure 5E and F). Our data suggest that Capn4 is able to
stimulate the expression of OPN.
NF-kB is responsible for the Capn4-mediated
upregulation of OPN
It has been reported that Capn4 activates NF-kB in HeLa cells,
which is involved in the survival pathway [36]. Therefore, we
speculated that NF-kB may be involved in the Capn4-induced
upregulation of OPN. Luciferase reporter gene assays revealed
that the knockdown of NF-kB (Si-NF-kB) resulted in the
Figure 3. OPN is responsible for the HBx-mediated upregulation of Capn4. (A, B and C) HepG2-X (or H7402-X) cells were transfected with
the indicated doses of siRNA targeting OPN mRNA (Si-OPN) and control siRNA for 48 h. (A) The promoter activity of Capn4 was detected by luciferase
reporter gene assay (**P,0.01, *P,0.05 Student’s t test). (B) The mRNA levels of Capn4 were detected by RT-PCR. (C) The protein levels of Capn4
were examined by western blot analysis. (D, E and F) HepG2 (or H7402) cells were transiently transfected with the indicated doses of pcDNA3.0-OPN
for 48 h. (D) The promoter activity of Capn4 was measured by luciferase reporter gene assay (*P,0.05 Student’s t test). (E, F) The mRNA and protein
levels of Capn4 were examined by RT-PCR and western blot analysis, respectively.
doi:10.1371/journal.pone.0031458.g003
Signal Pathway of Cell Migration Mediated by HBx
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Capn4 in a dose-dependent manner (Figure 6A). Additionally, the
upregulation of Capn4 mediated by OPN could be attenuated by
Si-NF-kB at the levels of mRNA and protein in a dose-dependent
manner (Figure 6B and C). Thus, we conclude that NF-kBi s
responsible for the Capn4-mediated upregulation of OPN.
Figure 4. NF-kB is responsible for the OPN-mediated upregulation of Capn4. (A, B and C) OPN-overexpressed HepG2 (or H7402) cells were
treated with the indicated doses of siRNA targeting NF-kB mRNA (Si-NF-kB) for 48 h. (A) The promoter activity of Capn4 was examined by reporter
gene assay (**P,0.01 Student’s t test). (B) The mRNA levels of Capn4, OPN and NF-kB/p65 were detected by RT-PCR. (C) The protein levels of Capn4,
OPN and NF-kB/p65 were measured by western blot analysis.
doi:10.1371/journal.pone.0031458.g004
Signal Pathway of Cell Migration Mediated by HBx
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hepatoma cell migration
Furthermore, we examined the effect of OPN and Capn4 on the
migration of hepatoma cells mediated by HBx. Wound healing
assays showed that HepG2-X cells exhibited a much greater ability
to repair the wound compared to control cells. However, the
migration ability of HepG2-X cells could be suppressed by the
treatment with siRNAs targeting HBx, OPN, Capn4 and NF-kB
(Figure S5A, B and Figure S6A, B, see Text S1), respectively. The
transient transfection of pCMV-X significantly promoted the
migration of HepG2 cells, but the transient transfection of pCMV-
HBc or pCMV-HBs failed to enhance the migration. In addition,
the transient transfection of pcDNA-OPN and pcDNA-Capn4
also promoted the migration of HepG2 cells (Figure S5C, S5D, see
Text S1), suggesting that OPN and Capn4 are involved in the
promotion of HBx-mediated hepatoma cell migration.
Figure 5. Capn4 can regulate OPN in a positive feedback manner. (A, B and C) HepG2-X (or H7402-X) cells were transfected for 48 h with the
indicated doses of siRNA targeting Capn4 mRNA (Si-Capn4). (A) The promoter activity of OPN was measured by luciferase reporter gene assay
(*P,0.05, Student’s t test). (B, C) The mRNA and protein levels of OPN were detected by RT-PCR and western blot analysis, respectively. (D, E and F)
HepG2 cells were transiently transfected with the indicated doses of pcDNA3.0-Capn4 for 48 h. (D) The promoter activity of OPN was measured by
luciferase reporter gene assay (*P,0.05 Student’s t test). (E, F) The mRNA and protein levels of OPN were examined by RT-PCR and western blot
analysis, respectively.
doi:10.1371/journal.pone.0031458.g005
Signal Pathway of Cell Migration Mediated by HBx
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Recent studies have shown that HBx is associated with cell
migration. Moreover, our previous studies demonstrated that HBx
is able to promote cell migration through the regulation Capn4 or
mir-29a [19,37]. However, the mechanisms of promotion of cell
migration mediated by HBx are not fully understood. In the
present study, we investigated the signaling pathways of hepatoma
cell migration mediated by HBx. Studies demonstrate that OPN is
closely related to tumor metastasis and is often overexpressed in
multiple tumor tissues and correlated with metastatic tissues
[22,23]. Thus, we first tested whether HBx was able to upregulate
OPN. The data demonstrated that HBx significantly upregulated
OPN in HepG2-X (or H7402-X) cells. Our laboratory previously
found that 5-LOX and COX-2 were involved in cell proliferation
and migration [10,11]. Accordingly, 5-LOX is often overexpressed
Figure 6. NF-kB is responsible for the Capn4-mediated upregulation of OPN. (A, B and C) Capn4-overexpressed HepG2 (or H7402) cells
were treated with the indicated doses of siRNA targeting NF-kB mRNA (Si-NF-kB) for 48 h. (A) The promoter activity of OPN was examined by
luciferase reporter gene assay (**P,0.01 Student’s t test). (B) The mRNA levels of OPN, Capn4 and NF-kB/p65 were detected by RT-PCR. (C) The
protein levels of OPN, Capn4 and NF-kB/p65 were measured by western blot analysis.
doi:10.1371/journal.pone.0031458.g006
Signal Pathway of Cell Migration Mediated by HBx
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that 5-LOX or COX-2 may be involved in the HBx-mediated
upregulation of OPN. Interestingly, we showed that HBx could
induce the upregulation of OPN in HepG2-X (or H7402-X) cells
through 5-LOX, rather than COX-2 (Figure 1). We then
examined the mechanism of HBx-mediated upregulation of 5-
LOX. It has been reported that the constitutive activation of NF-
kB is prevalent in liver tumor tissues [38]. NF-kB is one of
important transcription factors regulated by HBx, which induces
the expression of various target genes with various functions, such
as, proliferation and migration [13,14,15,16]. Therefore, we
speculated that NF-kB may be involved in the regulation of 5-
LOX expression mediated by HBx. Our results demonstrated that
the treatment with PDTC (a specific NF-kB inhibitor) and siRNAs
against NF-kB abolished the HBx-mediated upregulation of 5-
LOX (Figure 2), suggesting that NF-kB is responsible for the
upregulation of 5-LOX.
Our laboratory reported that HBx can upregulate Capn4
through NF-kB in the promotion of hepatoma cell migration [19].
Capn4 is a regulated subunit of calpains, and plays important roles
in the regulation of intracellular activities, including cell spreading
and migration [39], proliferation, apoptosis and differentiation
[40]. Accordingly, OPN can promote tumor cell migration via the
regulation of multiple signaling pathways and activation of
metastasis-related gene expression. Thus, we supposed that OPN
may be involved in the activation of Capn4 mediated by HBx.
Our data confirmed that OPN was responsible for the upregula-
tion of Capn4 in HepG2-X (or H7402-X) cells (Figure 3). Several
studies have reported that OPN can promote down-stream
effectors, such as metastasis-related genes, through the activation
of the NF-kB pathway [28,30]. We next examined whether NF-kB
was involved in the OPN-mediated upregulation of Capn4. The
results showed that NF-kB was responsible for the event (Figure 4).
HBx frequently regulates signal transduction in a feedback manner
[35]. Then, we examined that whether Capn4 is involved in the
activation of OPN. Our data showed that Capn4 was able to
upregulate OPN in a positive feedback manner (Figure 5). NF-kB
plays an important role in regulation of 5-LOX and OPN
mediated by HBx as above. Thus, we try to demonstrate whether
Capn4 regulates OPN through NF-kB as well. Our finding
showed that NF-kB was also involved in the Capn4-mediated
upregulation of OPN indeed (Figure 6), suggesting that NF-kBi s
an important factor in regulation of proteins involving cell
migration. To show that the above observations are relevant to
HBx expression during an HBV infection, we further examined
the effect of HBx on regulation of NF-kB, 5-LOX, OPN and
Capn4 in HepG2.2.15 cells using HBx RNAi. We found that HBx
was able to upregulate the expression of the proteins in the cells
(Figure S3). Meanwhile, we showed that the overexpression of
hepatitis B virus surface antigen (HBsAg) gene or hepatitis B virus
core antigen (HBcAg) gene failed to affect the promoter activities
of OPN and Capn4 (Figure S4), supporting that HBx is
responsible for the upregulation of NF-kB, 5-LOX, OPN and
Capn4. In function, we revealed that those factors such as OPN,
Capn4 and NF-kB were involved in hepatoma cell migration
promoted by HBx (Figure S5, S6). Interestingly, our finding
showed that a multiple factors such as NF-kB, 5-LOX, OPN and
Capn4 were involved in the regulation of cell migration meditated
by HBx with a cascade signaling transduction, in which NF-kB
was responsible for regulation of all other three factors. Growing
evidence reported that HBx, OPN and Capn4 were able to
activate transcription factor NF-kB [13,28,30,36]. Importantly,
OPN and Capn4 affected each other through NF-kB in a positive
feedback loop. The data suggested that those factors regulate cell
migration in a network manner. Thus, HBx drives a multiple
signaling, such as, NF-kB, 5-LOX, OPN and Capn4, in positive
feedback loop manner to promote hepatoma cell migration.
Taken together, we conclude that HBx can enhance hepatoma
cell migration through the activation of NF-kB, 5-LOX, OPN and
Capn4 cascade loops with multiple cross-talk events, which
contribute to the sustained promotion of cell migration mediated
by HBx. Moreover, NF-kB plays an important role in the cascade
loops of signaling pathways. Our finding provides new insight into
the mechanism of hepatoma cell migration promoted by HBx.
Materials and Methods
Plasmids, reagents and siRNAs
The plasmids pCMV-X, pcDNA3.0, pSilencer3.0-X, pGL3-
Basic, pGL3-control, pGL3-Capn4 and renilla luciferase reporter
vector pRL-TK were previously described [19,41]. The pGL3-
OPN plasmid was the firefly luciferase reporter plasmid containing
the full-length OPN promoter sequence [42]. The pcDNA3.0-
OPN and pcDNA3.0-Capn4 plasmid were the eukaryotic
expression vector containing the full-length OPN or Capn4
mRNA sequence. MK886 (an inhibitor of 5-LOX), Pyrrolidine
dithiocarbamate (PDTC, an inhibitor of NF-kB) and indometh-
acin (Indo, an inhibitor of COX-2) were purchased from Sigma-
Aldrich (USA). The enzyme immunoassay kit used for measure-
ment of leukotriene B4 (LTB4) was purchased from Adlitteram
Diagnostic Laboratories (USA). The siRNAs targeting the human
mRNA of OPN (targeting sequence: 59-GCCACAAGCAGTC-
CAGATT-39; D28759) [43], 5-LOX (targeting sequence: 59-
GCGCAAGTACTGGCTGAATGA-39; NM_000698), NF-kB/
p65 (targeting sequence: 59-ACAAGGTGCAGAAAGAGGACA-
39; NM_021975) [44], Capn4 (targeting sequence: 59-
GCTTTTGTTCTCTCAGTAC-39; NM_001749) [13] and the
negative control siRNA were designed and synthesized by RiboBio
(Guangzhou, China).
Cell culture
Human hepatoma HepG2 and H7402 cells, HepG2-P/H7402-
P cells (stably transfected with the empty pCMV-Tag2B vector
plasmid) and HepG2-X/H7402-X cells (stably transfected with the
pCMV-X plasmid) were maintained in Dulbecco’s modified
Eagle’s (DMEM) medium (Gibco, USA) supplemented with heat
inactivated 10% fetal calf serum (FCS), 100 U/ml penicillin, and
100 mg/ml streptomycin in a humidified atmosphere of 5% CO2
and 95% air at 37uC [35].
Construction of the human OPN and Capn4 eukaryotic
expression plasmid
The full-length human OPN cDNA (942 bp, Gen ID: 6696)
and human Capn4 cDNA (801 bp, Gen ID: 826) were cloned into
the EcoRI and XhoI sites of the eukaryotic expression vector
pcDNA3.0, using human cDNA as a template, termed pcDNA3.0-
OPN or pcDNA3.0-Capn4, respectively. The primers used are
listed in table S1.
RNA interference (RNAi)
HepG2-X (or H7402-X) cells were transfected with the
pSilencer-X vector that produces siRNA that targets the HBx
mRNA or with control siRNA [41]. Duplex siRNAs targeting the
human mRNA of OPN, 5-LOX and Capn4 were introduced into
HepG2-X (or H7402-X) cells according to the manufacturer’s
instructions. Duplex siRNA targeting the human NF-kB/p65
mRNA were transfected into HepG2 (or H7402) cells with
overexpression of OPN according to the manufacturer’s instruc-
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transfection reagent and control siRNA. The transfected cells were
subjected to luciferase reporter gene assays, RT-PCR and western
blot analysis 48 h after the transfection.
Treatment of tumor cells
HepG2-X cells were cultured in serum-free medium for 12 h.
Briefly, the engineered cells were treated with MK886 (5, 10 or
20 mM), Indo (10, 20 or 50 mM) and PDTC (20, 40 or 60 mM) for
6 h. The treated cells were used to perform luciferase reporter
gene assays. The examination of cytotoxicity mediated by MK886
and Indo has been performed [35].
Transfection
Transfection was performed in cells using Lipofectamine 2000
(Invitrogen, USA). In brief, the cells were plated in 6-well or 96-
well plates at 50% confluence. For each well, siRNA was added
into 250 ml Opti-MEM medium (Gibco), and 5 ml Lipofectamine
2000 was added into 250 ml Opti-MEM medium and mixed well.
The mixture was added and incubated for 6 h before the medium
was replaced.
Luciferase reporter gene assays
Cells (2610
5) were plated in a 24-well culture plate and
transfected with 300 ng reporter plasmid with 50 ng of pRL-TK
encoding renilla luciferase. The treated cells were harvested after
48 h and lysed in 16 passive lysis buffer. The luciferase activity
was determined using Dual-Luciferase ReporterH Assay System
(Promega, USA) on a Luminometer (TD-20/20, Turner Designs)
according to the manufacturer’s instructions. Promoter activity
was analyzed by detecting firefly luciferase activity and normal-
izing to renilla luciferase activity in each well, as previously
described [41]. Each assay was performed in triplicate.
RNA extraction, RT-PCR and real-time PCR
Total RNA extraction and reverse transcription were carried out
as described previously [45]. Synthesized cDNA was used as a
template for PCR (primers are listed in table S1). The RT-PCR
products were verified by electrophoresis on a 1% ethidium
bromide-stained agarose gel. Quantitative real-time PCR was
performed using the SYBRH Premix Ex TaqTM II PCR kit
(Takara, Japan) by following the manufacturer’s instructions. The
relative amounts of mRNAs were calculated using the DDCtmethod
[46] with GAPDH as the endogenous reference gene amplified from
the samples. All experiments were performed in triplicate.
Western blot analysis
After indicated treatments, the cells were washed three times
with ice-cold phosphate-buffered saline (PBS). The cytosolic
extracts were extracted with lysis buffer (62.5 mM Tris–HCl,
pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, and
protease inhibitor cocktail). Nuclear extracts were collected using
NEPER Nuclear and Cytoplasmic Extraction kit (Pierce Biotech-
nology, USA). The western blot protocol was described previously
[35]. The primary antibodies used were against b-actin (1:1000
dilution, Sigma-Aldrich, USA), HBx (1:1000 dilution, Abcam,
UK),Capn4 (1:1000 dilution, Thermo Fisher Scientific, USA),
OPN (1:800 dilution, provided by Dr. Chao Bian from Shanghai
institutes for biological sciences, Chinese Academy of Sciences), 5-
LOX (Santa Cruz Biotechnology, USA),histone-3 (Cell Signaling
Technology, USA) and NF-kB/p65 (1:400 dilution, Santa Cruz
Biotechnology, USA). All experiments were performed in
triplicate.
Enzyme-linked immunosorbent assay (ELISA)
The amount of LTB4 (a metabolite of 5-LOX) was examined
by ELISA according to the manufacturer’s instructions. The
concentration of LTB4 was normalized to the total protein. The
protein concentrations in these extracts were determined by a
standard protein assay method (Bio-Rad Laboratories, Inc., USA).
All experiments were performed in triplicate.
Statistical analysis
All values are presented as means 6 SEM. Each value is the
mean of at least three separate experiments in each group. Data
were analyzed by comparing two groups using Student’s t test.
P,0.05 was considered significant.
Supporting Information
Figure S1 HBx upregulates the expression of OPN. (A)
The promoter activity of OPN was examined by luciferase
reporter gene assay in HepG2-X (or H7402-X) cells, which was
abolished by RNAi targeting HBx mRNA, using the indicated
doses of pSilencer3.0-X (pSi-HBx) plasmid (**P,0.01 Student’s t
test). (B) The protein expression of OPN was detected in HepG2-X
(or H7402-X) cells by western blot analysis, which was attenuated
by pSi-HBx plasmid in a dose-dependent manner.
(TIF)
Figure S2 HBx upregulates the expression of 5-LOX. (A)
The expression of 5-LOX was examined by real-time PCR in
HepG2-X (or H7402-X) cells, which was abolished by using
pSilencer3.0-X plasmid (***P,0.001, Student’s t test). (B) The
expression level of 5-LOX and HBx were detected by western blot
analysis. (C,D) The level of LTB4, a metabolite of 5-LOX, was
determined by ELISA in conditioned media or in cell lysates from
HepG2-X (or H7402-X) cells (*P,0.05, **P,0.01, ***P,0.00l,
Student’s t test).
(TIF)
Figure S3 HBx upregulates NF-kB, 5-LOX, OPN and
Capn4 in HepG2.2.15 cells. The expression levels of NF-kB, 5-
LOX, OPN, Capn4 and HBx were detected by western blot analysis.
(TIF)
Figure S4 HBx increases the promoter activity of OPN
and Capn4, but not by HBc and HBs. (A) The promoter
activity of OPN was examined by luciferase reporter gene assay in
HepG2 cells (**P,0.01 Student’s t test). (B) The promoter activity
of Capn4 was examined by luciferase reporter gene assay in
HepG2 cells (**P,0.01 Student’s t test).
(TIF)
Figure S5 HBx promotes hepatoma cell migration
through OPN and Capn4, but not by HBc and HBs. (A)
The migration ability of hepatoma cells was examined by wound
healing assay when the cells were treated by pSi-HBx, Si-OPN or
Si-Capn4. Black arrows indicate the wound edge closure of
monolayer cells. (B) The average migration distances of the wound
edge were measured in three independent experiments (*P,0.05,
**P,0.01, Student’s t test). (C) The migration ability of hepatoma
cells was examined by wound healing assay when HBx, HBs, HBc,
OPN and Capn4 were overexpressed in the cells. Black arrows
indicatethe wound edge closureofmonolayercells.(D)Theaverage
migration distances of the wound edge were measured in three
independent experiments (*P,0.05, **P,0.01, Student’s t test).
(TIF)
Figure S6 HBx promotes cell migration through NF-kB.
(A)Themigration ability ofhepatoma cells was examined by wound
Signal Pathway of Cell Migration Mediated by HBx
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average migration distances of the wound edge were measured in
three independent experiments (***P,0.001, Student’s t test).
(TIF)
Table S1 List of primers used for PCR analysis.
(DOC)
Text S1 Supporting information.
(DOC)
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